Veracyte

Veracyte, Inc. is a genomic diagnostics company that focuses on improving diagnostic accuracy for various diseases, particularly in oncology and pulmonology. They make money by developing and selling advanced genomic tests that help physicians make more informed treatment decisions, thereby reducing unnecessary surgeries and other procedures. Founded in 2008, Veracyte has made significant strides in the diagnostics field, including the development of the Afirma Thyroid FNA Analysis and the Percepta Bronchial Genomic Classifier, which have become critical tools in clinical settings.

Recent Posts by Veracyte

1-20 of 32